New research found that gene therapy for children with a form of severe combined immunodeficiency was successful in 95% of ...

Even in death, cells leave a trace. Scientists have discovered a microscopic “Footprint of Death” that not only helps the ...

A new study from The University of Texas at Arlington has revealed how cells control their mitochondria—the "energy producers ...

UTA doctoral student Rashna Sharmin's discovery could help scientists better understand brain development and disease. (UTA ...

Scientists are hoping to treat diseases including cancer and Alzheimer's by influencing how cells make life-or-death decisions.

Designation supported by results from multiple dose cohorts from the Phase 1/1b trial of ficerafusp alfa in 1L HPV-negative R/M HNSCCBOSTON, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc.

HIV remains a major global health issue, affecting nearly 40 million people worldwide. Current treatments, known as antiretroviral therapy (ART), are highly effective at suppressing the virus and ...

Gilead and Arcus Bioscience’s monoclonal antibody (mAb), domvanalimab, has produced positive results in a Phase II ...

If approved in RCC, fruquintinib will be available for three indications, including endometrial and colorectal cancer.

MIT and Harvard scientists have designed an advanced type of immune cell called a CAR-NK cell that can destroy cancer while ...

Researchers sought to determine whether isatuximab and cemiplimab would be safe and effective for patients with relapsed/refractory extranodal NK/T-cell lymphoma.